V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005628 | 280003561 | 1.85 | null | Palliative (P) | 2016-05-12 | 2016-06-01 | Capecitabine | N | N | 280029425 | SUNITINIB |
| 280005629 | 280003562 | 1.79 | 92 | Curative (C) | 2014-08-17 | 2014-09-03 | IVADo | Y | N | 280029427 | IMATINIB |
| 280005630 | 280007901 | null | 69.5 | null | 2016-03-07 | 2016-03-07 | BENDAMUSTINE + RITUXIMAB | 1 | Y | 280029428 | BORTEZOMIB |
| 280005631 | 280003563 | 1.73 | null | Palliative (P) | 2017-11-28 | 2017-12-27 | Capecitabine + Cisplatin | N | N | 280029432 | CARBOPLATIN + CETUXIMAB + FU |
| 280005632 | 280007902 | 0 | 119.6 | Palliative (P) | 2013-11-25 | 2013-12-17 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280029437 | CARBOPLATIN + CETUXIMAB + FU |
| 280005633 | 280003564 | 1.84 | 87.4 | Curative (C) | 2015-10-15 | 2015-11-01 | Dasatinib | N | N | 280029438 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280005634 | 280003564 | 1.39 | 40.6 | Palliative (P) | null | 2017-04-08 | VAC | N | N | 280029438 | CHLORAMBUCIL |
| 280005635 | 280010026 | 1.71 | 69.8 | Palliative (P) | 2015-05-23 | 2015-05-24 | Ifosfamide | N | N | 280029442 | PACLITAXEL |
| 280005636 | 280011083 | 1.73 | 67.1 | Neo-adjuvant (N) | 2013-10-10 | 2013-10-12 | BENDAMUSTINE + RITUXIMAB | N | N | 280029443 | VIDE |
| 280005637 | 280003565 | 1.59 | 89 | Palliative (P) | 2018-03-18 | 2018-03-23 | DABRAFENIB + TRAMETINIB | N | N | 280029445 | CAPE + CARBOPLATIN + CETUXIMAB |
| 280005638 | 280007904 | 1.62 | null | Neo-adjuvant (N) | 2016-07-15 | 2016-07-16 | VIDE | 02 | N | 280029446 | CAV |
| 280005639 | 280003566 | 1.91 | 82.9 | Curative (C) | 2013-11-27 | 2013-11-27 | GemCarbo Days 1+8 | N | N | 280029448 | DE-ESCALATE TRIAL |
| 280005640 | 280003567 | 1.66 | null | Curative (C) | 2017-05-03 | 2017-05-08 | CAPECITABINE + OXALIPLATIN | N | N | 280029449 | DE-ESCALATE TRIAL |
| 280005641 | 280007905 | 1.74 | 96.9 | Not known (9) | 2018-01-09 | 2018-01-09 | Oxaliplatin + Modified de Gramont | 02 | Y | 280029450 | PACLITAXEL |
| 280005642 | 280003568 | null | 54.3 | Palliative (P) | 2014-02-05 | 2014-02-05 | Doxorubicin + Olaratumab | 02 | N | 280029451 | CARBO + FLUOROURACIL |
| 280005643 | 280003568 | 1.7 | null | Palliative (P) | 2019-01-01 | 2019-01-15 | Gemcitabine weekly | N | N | 280029451 | IRINOTECAN + MDG |
| 280005644 | 280003569 | 0 | 90 | Palliative (P) | 2016-07-13 | 2016-10-04 | Abiraterone | N | N | 280029453 | CISPLATIN + DOXORUBICIN |
| 280005645 | 280003570 | null | 68.2 | Palliative (P) | 2014-08-31 | 2014-08-31 | Etoposide + Ifosfamide (3 days) | 2 | N | 280029456 | DOXORUBICIN + OLARATUMAB |
| 280005646 | 280007907 | null | -1 | Neo-adjuvant (N) | 2013-11-18 | 2014-03-28 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 280029458 | DOCETAXEL + GEMCITABINE |
| 280005647 | 280007907 | 2 | 86.3 | Curative (C) | 2018-01-23 | 2018-01-31 | Cyclophosphamide + Topotecan | N | N | 280029458 | DE-ESCALATE TRIAL |
| 280005648 | 280003571 | 1.74 | 78 | Neo-adjuvant (N) | 2016-06-05 | 2016-06-21 | CompARE Trial | 02 | Y | 280029460 | CAV |
| 280005649 | 280003572 | 1.9 | 79.1 | Adjuvant (A) | 2015-02-25 | 2015-03-25 | ECX | N | N | 280029462 | CISPLATIN + VINORELBINE |
| 280005650 | 280003573 | null | null | null | 2016-12-07 | 2016-12-17 | Cetuximab + CISPLATIN | null | null | 280029464 | ETOPOSIDE + IFOSFAMIDE |
| 280005651 | 280003573 | 1.63 | 65 | Curative (C) | null | 2013-12-18 | PATHOS Trial | Y | N | 280029464 | RMS 2005 TRIAL |
| 280005652 | 280003574 | 1.57 | 93.4 | Curative (C) | 2015-12-19 | 2015-12-22 | PACLITAXEL | 02 | N | 280029467 | IVA |
| 280005653 | 280003575 | 1.79 | 97 | Palliative (P) | 2017-11-14 | 2017-11-18 | CompARE Trial | Y | Y | 280029469 | CARBOPLATIN + CETUXIMAB + FU |
| 280005654 | 280007909 | 1.71 | 54 | Palliative (P) | 2017-10-11 | 2017-10-18 | Paclitaxel 7 day | Y | Y | 280029470 | CISPLATIN + CETUXIMAB |
| 280005655 | 280007909 | 1.76 | 65 | Curative (C) | null | 2016-02-25 | Trabectedin | 01 | null | 280029470 | PACLITAXEL |
| 280005656 | 280003576 | 1.65 | 122.8 | null | null | 2014-04-06 | Fluorouricil + Folonic Acid (MdG) | null | null | 280029472 | CARBO + FLUOROURACIL |
| 280005657 | 280003576 | null | null | Curative (C) | 2015-04-20 | 2015-04-23 | Capecitabine | Y | N | 280029472 | IVA |
| 280005658 | 280003577 | 0 | 77.7 | Palliative (P) | 2018-05-28 | 2018-05-31 | Doxorubicin + Olaratumab | Y | N | 280029475 | TRABECTEDIN |
| 280005659 | 280003577 | 1.76 | 76 | Neo-adjuvant (N) | 2015-04-29 | 2015-05-09 | CETUXIMAB + IRINOTECAN + MDG | N | N | 280029475 | CISPLATIN + FLUOROURACIL + RT |
| 280005660 | 280003578 | 1.53 | 91.6 | Curative (C) | 2016-12-25 | 2016-12-30 | Dacarbazine | 2 | N | 280029479 | CISPLATIN + FLUOROURACIL + RT |
| 280005661 | 280003578 | 1.73 | 51.4 | Curative (C) | 2014-11-15 | 2014-11-27 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 1 | N | 280029479 | IVA |
| 280005662 | 280003579 | 1.7 | 59.2 | Curative (C) | 2013-08-05 | 2013-08-12 | IMATINIB | 2 | null | 280029481 | VINCRISTINE |
| 280005663 | 280003579 | null | 60.6 | null | null | 2018-01-16 | Sunitinib | null | null | 280029481 | IVADO |
| 280005664 | 280003579 | null | 62.2 | Palliative (P) | 2016-04-28 | 2016-05-09 | Streptozocin + MdG | N | N | 280029481 | CARBO + FLUOROURACIL |
| 280005665 | 280003579 | 1.64 | null | Palliative (P) | 2017-10-13 | 2017-10-17 | Doxorubicin + Olaratumab | 1 | N | 280029481 | PAZOPANIB |
| 280005666 | 280003579 | null | 12.4 | Palliative (P) | 2012-02-19 | 2012-02-29 | BENDAMUSTINE + RITUXIMAB | N | null | 280029481 | VIDE |
| 280005667 | 280011856 | null | null | Palliative (P) | 2016-06-29 | 2016-07-10 | Paclitaxel 7 day | N | N | 280029491 | DOCETAXEL |
| 280005668 | 280011856 | null | 116.8 | Palliative (P) | 2017-03-19 | 2017-03-31 | LANREOTIDE | N | N | 280029491 | DOXORUBICIN + OLARATUMAB |
| 280005669 | 280011856 | 1.73 | 95 | null | 2013-08-02 | 2013-09-03 | Capecitabine | 02 | Y | 280029491 | GEDDIS TRIAL |
| 280005670 | 280011856 | 1.9 | 90.9 | Adjuvant (A) | 2013-04-08 | 2013-04-08 | Trabectedin | 2 | N | 280029491 | CISPLATIN + DOXORUBICIN |
| 280005671 | 280011856 | 1.44 | 59.3 | Palliative (P) | 2018-01-30 | 2018-02-11 | Cetuximab +Cisplatin + FU (Cycle 1) | 99 | null | 280029491 | DOXORUBICIN + OLARATUMAB |
| 280005672 | 280011856 | null | 62 | Curative (C) | 2016-02-06 | 2016-04-02 | Paclitaxel 7 day | null | null | 280029491 | CISPLATIN + FLUOROURACIL + RT |
| 280005673 | 280011856 | 1.97 | 86.3 | Palliative (P) | 2017-04-10 | 2017-04-13 | Cisplatin + Vinorelbine (IV) | N | N | 280029491 | CASPS TRIAL |
| 280005674 | 280003580 | 1.65 | 85.6 | null | null | 2013-08-07 | Liposomal Doxorubicin (Caelyx) | null | null | 280029502 | CAPECITABINE + CISPLATIN |
| 280005675 | 280003581 | null | 57 | Neo-adjuvant (N) | 2016-03-29 | 2016-03-31 | EW EuroEwing 99 : VIDE | 02 | N | 280029506 | CARBO + FLUOROURACIL |
| 280005676 | 280003581 | 1.61 | null | null | 2015-03-02 | 2015-03-09 | Doxorubicin + Olaratumab | N | N | 280029506 | CARBO + FLUOROURACIL |
| 280005677 | 280003581 | null | null | null | 2016-01-20 | 2016-02-11 | FLUOROURACIL + MITOMYCIN + RT | N | Y | 280029506 | VIDE |